The lawsuit, filed by Novartis against Missouri’s attorney general and members of the Missouri Board of Pharmacy, challenges a new state law expanding the discount requirement of the 340B program to include for-profit pharmacies. Novartis argues that the way the law forces the organization to discount drugs will further harm its business model.
In the motion, filed Aug. 29 and posted on the AHA’s website, the three organizations ask that the court dismiss Novartis’ lawsuit and to prevent the obstruction of the new law, which the organizations say protects the 340B program.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
